Targeting Mononuclear Phagocyte Receptors in Cancer Immunotherapy: New Perspectives of the Triggering Receptor Expressed on Myeloid Cells (TREM-1)
Inflammatory cells are major players in the onset of cancer. The degree of inflammation and type of inflammatory cells in the tumor microenvironment (TME) are responsible for tilting the balance between tumor progression and regression. Cancer-related inflammation has also been shown to influence th...
Main Authors: | Federica Raggi, Maria Carla Bosco |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/5/1337 |
Similar Items
-
Reinforcing the Functionality of Mononuclear Phagocyte System to Control Tuberculosis
by: Susanta Pahari, et al.
Published: (2018-02-01) -
Prenatal Development and Function of Human Mononuclear Phagocytes
by: Mohi Miah, et al.
Published: (2021-04-01) -
Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD
by: Hong Liu, et al.
Published: (2019-11-01) -
Regulation of Human Macrophage M1–M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1
by: Federica Raggi, et al.
Published: (2017-09-01) -
Manipulation of Mononuclear Phagocytes by HIV: Implications for Early Transmission Events
by: Kirstie Melissa Bertram, et al.
Published: (2019-09-01)